Company: PHR
Filing Date: 2025-05-14
Form Type: DEF 14A
Source: 0001412408-25-000027
Chunk: 8

Company: Phreesia, Inc.
Filing Date: 2025-05-14
Form: DEF 14A
Chunk 8
---
 participate in the Annual Meeting online and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/PHR2025. You will also be able to vote your shares electronically prior to or during the Annual Meeting.                                                                                                                                                                                                                                                                                                             |
|:--------------------------------------------------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Who pays for the cost of this proxy solicitation? |     | Our Board is soliciting proxies for use at the Annual Meeting. We will bear the cost of preparing and distributing these proxy materials and we may reimburse brokerage houses and other custodians, nominees and fiduciaries for their reasonable expenses in forwarding solicitation materials to our stockholders. Proxies may be solicited by certain of our directors, officers and employees, personally or by mail, telephone, facsimile, email or other means of communication (electronic or otherwise). No additional compensation will be paid for such services. |

<div align='center'>9

PROPOSAL ONE:</div>

### ELECTION OF DIRECTORS

#### Number of Directors; Board Structure
Our Board is currently composed of eight members. In accordance with our Seventh Amended and Restated Certificate of Incorporation, as amended, our Board is divided into three staggered classes of directors with one class elected each year at the annual meeting of stockholders for a term of three years. Directors are expected to be elected to hold office for such three-year term or until the election and qualification of their successors in office, subject to their earlier resignation, death or removal. At the Annual Meeting two Class III directors named in this Proxy Statement are standing for election to the Board for a term that will expire at the 2028 annual meeting of stockholders.

#### Nominees
Upon the recommendation of our nominating and corporate governance committee, our Board has nominated Gillian Munson and Mark Smith, M.D. for re-election as Class III directors, to hold office until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified, subject to their earlier resignation, death or removal. Each of the nominees is a current Class III director and member of our Board and has consented to serve if elected.

Unless you direct otherwise through your proxy voting instructions, the persons named as proxies will vote all proxies received “ FOR ” the election of each nominee. If any nominee is unable or unwilling to serve at the time of the Annual Meeting, the persons named as proxies may vote for a substitute nominee chosen by our present Board. In the alternative